Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung disease drug trial in kids halted early

NCT ID NCT02615938

Terminated Disease control Sponsor: Matthias Griese Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether hydroxychloroquine could help children with a rare lung condition called interstitial lung disease. About 35 children were planned to take either the drug or a placebo to see if their oxygen levels or breathing improved. The trial was stopped early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN´S INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease interstitial lung disease specific to childhood primary interstitial lung disease specific to childhood

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDREN´S INTERSTITIAL LUNG DISEASE DIFFUSE PARENCHYMAL LUNG DISEASE INTERSTITIAL LUNG DISEASE

Contacts and locations

Locations

  • Charité Berlin, Klinik für Pädiatrie

    Berlin, 13353, Germany

  • Justus-Liebig-Universität, Allgemeine Pädiatrie u. Neonatologie

    Giessen, Hesse, 35385, Germany

  • Klinik u. Poliklinik für Kinder- u. Jugendmedizin der Universität Leipzig

    Leipzig, Saxony, 04103, Germany

  • Klinikum der Universität München, Haunersches Kinderspital

    München, Bavaria, 80337, Germany

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, 30625, Germany

  • St. Joseph- und St. Elisabeth Hospital gGmbH

    Bochum, North Rhine-Westphalia, 44791, Germany

  • Uniklinikum Essen, Pädiatrische Pneumologie

    Essen, North Rhine-Westphalia, 45122, Germany

  • Universitätsklinik für Kinder- und Jugendmedizin Tübingen

    Tübingen, Baden-Wurttemberg, 72076, Germany

  • Universitätsklinikum Frankfurt, Pneumologie, Allergologie, Mukoviszidose

    Frankfurt am Main, Hesse, 60590, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.